Plasma clinical trials
Plasma is named as an intervention in 4 current clinical trials in our USA, Canada, Israel and Egypt registers. 2 are recruiting patients now. The most common phase is Phase 1. The sponsor with the most trials is Vitruvian Medical Devices, Inc (1). The most-studied condition is Foot Ulcer, Diabetic.
Patient leaflets for Plasma
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Trials by status
Trials by phase
Clinical trials of Plasma
4 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
High-Titer Neutralizing Plasma for West Nile Fever in Hospitalized Patients
NCT07094724 · ClinicalTrials.gov ↗ · West Nile Fever
|
Phase 2 | Recruiting | Gili Regev-Yochay MD | Israel |
|
SWiFT Canada (Study of Whole Blood in Frontline Trauma)
NCT06495294 · ClinicalTrials.gov ↗ · Trauma
|
Not applicable | Recruiting | Unity Health Toronto | Canada |
|
A Split-Face Comparative Study of Mono Threads Versus Combination With Plasma Gel for the Treatment of Post-Acne Scars
NCT07903012 · ClinicalTrials.gov ↗ · Acne
|
Phase 2/3 | By invitation | Tanta University | Egypt |
|
Study to Assess the Safety of DERMASEAL for Diabetic Foot Ulcers
NCT05586542 · Foot Ulcer, Diabetic
|
Phase 1 | Active, closed | Vitruvian Medical Devices, Inc | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with Plasma
4 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Vitruvian Medical Devices, Inc | 1 |
| Unity Health Toronto | 1 |
| Gili Regev-Yochay MD | 1 |
| Tanta University | 1 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 1 | 0 |
| Clinical trials in Canada | 1 | 1 |
| Clinical trials in Israel | 1 | 1 |
| Clinical trials in Egypt | 1 | 0 |
A trial with sites in more than one country appears in each of those registers.
Questions about Plasma trials
How many clinical trials are testing Plasma?
4 current trials in our USA, Canada, Israel and Egypt registers name Plasma as a drug or biological intervention, as of the registry sync on 11 November 2026. Completed and withdrawn studies are not counted.
Are Plasma trials recruiting patients?
Yes. 2 of the 4 trials are recruiting: 1 with sites in Canada and 1 with sites in Israel. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Plasma clinical trials?
Vitruvian Medical Devices, Inc (1), Unity Health Toronto (1), Gili Regev-Yochay MD (1) and Tanta University (1). The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Plasma works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Plasma works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Plasma (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 11 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.